Clinical Trials Directory

Trials / Completed

CompletedNCT01800851

Calorimetry, Insulin Resistance and Energy Metabolism Study to Understand the Risk of Obesity in Kidney Transplanted Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
Male
Age
35 Years – 65 Years
Healthy volunteers
Accepted

Summary

Weight gain is a common complication after transplantation. It has adverse effects such as hypertension, dyslipidemia, and insulin resistance. Weight gain is implicated in the increased cardiovascular risk and the long-term loss of graft function. Weight loss achieved by a suitable dietary intervention in these patients transplanted kidney can correct lipid disorders and facilitate balance blood pressure. The identification of mechanisms responsible for weight gain would suggest prevention strategies and allow to align the caloric energy needs of renal transplant patients.

Detailed description

Weight gain is a common complication after transplantation. It has adverse effects such as hypertension, dyslipidemia, and insulin resistance. Weight gain is implicated in the increased cardiovascular risk and the long-term loss of graft function. Weight loss achieved by a suitable dietary intervention in these patients transplanted kidney can correct lipid disorders and facilitate balance blood pressure. The identification of mechanisms responsible for weight gain would suggest prevention strategies and allow to align the caloric energy needs of renal transplant patients.

Conditions

Interventions

TypeNameDescription
OTHEREnergy expenditure evaluation in calorimetric chamber

Timeline

Start date
2008-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2013-02-28
Last updated
2014-07-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01800851. Inclusion in this directory is not an endorsement.